Information Provided By:
Fly News Breaks for July 22, 2015
XOMA
Jul 22, 2015 | 12:57 EDT
Cowen downgraded Xoma to Market Perform after Gevokizumab failed in a Phase III trial to treat Behcet's uveitis patients.
News For XOMA From the Last 2 Days
There are no results for your query XOMA